The molecular determinants of CD8 co-receptor function

Immunology

Volumn 137, Issue 2, 2012, Pages 139-148

  Cole, David K ^a   Laugel, Bruno ^a   Clement, Mathew ^a   Price, David A ^a   Wooldridge, Linda ^a   Sewell, Andrew K ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

CD8, co receptor, biophysics; Crystal structure; Peptide major histocompatibility complex; T cell activation; T cell receptor

Indexed keywords

CD8ALPHABETA CO RECEPTOR; CELL PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL INTERACTION; CELL SPECIFICITY; CELL SURFACE; CELLULAR IMMUNITY; CROSS REACTION; HUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CROSS REACTIONS; HUMANS; LIGANDS; LYMPHOCYTE ACTIVATION; RECEPTORS, ANTIGEN, T-CELL;

EID: 84865719982     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2012.03625.x     Document Type: Article

References (79)

1. Davis MM, Bjorkman PJ. T-cell antigen receptor genes and T-cell recognition. Nature 1988; 334:395-402.
2. Moebius U, Kober G, Griscelli AL, Hercend T, Meuer SC. Expression of different CD8 isoforms on distinct human lymphocyte subpopulations. Eur J Immunol 1991; 21:1793-800.
3. Leishman AJ, Naidenko OV, Attinger A et al. T cell responses modulated through interaction between CD8αα and the nonclassical MHC class I molecule, TL. Science 2001; 294:1936-9.
4. Vremec D, Pooley J, Hochrein H, Wu L, Shortman K. CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J Immunol 2000; 164:2978-86.
5. Norment AM, Littman DR. A second subunit of CD8 is expressed in human T cells. EMBO J 1988; 7:3433-9.
6. Hayday A, Theodoridis E, Ramsburg E, Shires J. Intraepithelial lymphocytes: exploring the Third Way in immunology. Nat Immunol 2001; 2:997-1003.
7. Holler PD, Kranz DM. Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation. Immunity 2003; 18:255-64.
8. Janeway CA Jr. The T cell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation. Annu Rev Immunol 1992; 10:645-74.
9. Luescher IF, Vivier E, Layer A, Mahiou J, Godeau F, Malissen B, Romero P. CD8 modulation of T-cell antigen receptor-ligand interactions on living cytotoxic T lymphocytes. Nature 1995; 373:353-6.
10. Norment AM, Salter RD, Parham P, Engelhard VH, Littman DR. Cell-cell adhesion mediated by CD8 and MHC class I molecules. Nature 1988; 336:79-81.
11. Wooldridge L, van den Berg HA, Glick M et al. Interaction between the CD8 coreceptor and major histocompatibility complex class I stabilizes T cell receptor-antigen complexes at the cell surface. J Biol Chem 2005; 280:27491-501.
12. Turner JM, Brodsky MH, Irving BA, Levin SD, Perlmutter RM, Littman DR. Interaction of the unique N-terminal region of tyrosine kinase p56lck with cytoplasmic domains of CD4 and CD8 is mediated by cysteine motifs. Cell 1990; 60:755-65.
13. Veillette A, Bookman MA, Horak EM, Bolen JB. The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck. Cell 1988; 55:301-8.
14. Laugel B, Price DA, Milicic A, Sewell AK. CD8 exerts differential effects on the deployment of cytotoxic T lymphocyte effector functions. Eur J Immunol 2007; 37:905-13.
15. Purbhoo MA, Boulter JM, Price DA et al. The human CD8 coreceptor effects cytotoxic T cell activation and antigen sensitivity primarily by mediating complete phosphorylation of the T cell receptor ζ chain. J Biol Chem 2001; 276:32786-92.
16. Rybakin V, Clamme JP, Ampudia J, Yachi PP, Gascoigne NR. CD8αα and -αβ isotypes are equally recruited to the immunological synapse through their ability to bind to MHC class I. EMBO Rep 2011; 12:1251-6.
17. Arcaro A, Gregoire C, Bakker TR et al. CD8β endows CD8 with efficient coreceptor function by coupling T cell receptor/CD3 to raft-associated CD8/p56(lck) complexes. J Exp Med 2001; 194:1485-95.
18. Arcaro A, Gregoire C, Boucheron N, Stotz S, Palmer E, Malissen B, Luescher IF. Essential role of CD8 palmitoylation in CD8 coreceptor function. J Immunol 2000; 165:2068-76.
19. + T cells in the thymus. Immunity 2000; 12:409-18.
20. Bosselut R, Zhang W, Ashe JM, Kopacz JL, Samelson LE, Singer A. Association of the adaptor molecule LAT with CD4 and CD8 coreceptors identifies a new coreceptor function in T cell receptor signal transduction. J Exp Med 1999; 190:1517-26.
21. Zhang W, Trible RP, Samelson LE. LAT palmitoylation: its essential role in membrane microdomain targeting and tyrosine phosphorylation during T cell activation. Immunity 1998; 9:239-46.
22. Grakoui A, Bromley SK, Sumen C, Davis MM, Shaw AS, Allen PM, Dustin ML. The immunological synapse: a molecular machine controlling T cell activation. Science 1999; 285:221-7.
23. Laugel B, van den Berg HA, Gostick E et al. Different T cell receptor affinity thresholds and CD8 coreceptor dependence govern cytotoxic T lymphocyte activation and tetramer binding properties. J Biol Chem 2007; 282:23799-810.
24. Gao GF, Tormo J, Gerth UC et al. Crystal structure of the complex between human CD8α(α) and HLA-A2. Nature 1997; 387:630-4.
25. Leahy DJ, Axel R, Hendrickson WA. Crystal structure of a soluble form of the human T cell coreceptor CD8 at 2.6 Å resolution. Cell 1992; 68:1145-62.
26. Shi Y, Qi J, Iwamoto A, Gao GF. Plasticity of human CD8αα binding to peptide-HLA-A2402. Mol Immunol 2011; 48:2198-202.
27. Kern PS, Teng MK, Smolyar A et al. Structural basis of CD8 coreceptor function revealed by crystallographic analysis of a murine CD8αα ectodomain fragment in complex with H-2Kb. Immunity 1998; 9:519-30.
28. Chang HC, Tan K, Ouyang J et al. Structural and mutational analyses of a CD8αβ heterodimer and comparison with the CD8αα homodimer. Immunity 2005; 23:661-71.
29. Wang R, Natarajan K, Margulies DH. Structural basis of the CD8αβ/MHC class I interaction: focused recognition orients CD8β to a T cell proximal position. J Immunol 2009; 183:2554-64.
30. Bridgeman JS, Sewell AK, Miles JJ, Price DA, Cole DK. Structural and biophysical determinants of αβ T-cell antigen recognition. Immunology 2012; 135:9-18.
31. Buslepp J, Wang H, Biddison WE, Appella E, Collins EJ. A correlation between TCR Vα docking on MHC and CD8 dependence: implications for T cell selection. Immunity 2003; 19:595-606.
32. Yin Y, Wang XX, Mariuzza RA. Crystal structure of a complete ternary complex of T-cell receptor, peptide-MHC, and CD4. Proc Natl Acad Sci U S A 2012; 109:5405-10.
33. Kuhns MS, Davis MM. Disruption of extracellular interactions impairs T cell receptor-CD3 complex stability and signaling. Immunity 2007; 26:357-69.
34. Van Laethem F, Sarafova SD, Park JH et al. Deletion of CD4 and CD8 coreceptors permits generation of αβ T cells that recognize antigens independently of the MHC. Immunity 2007; 27:735-50.
35. Tikhonova AN, Van Laethem F, Hanada K etal. αβ T cell receptors that do not undergo major histocompatibility complex-specific thymic selection possess antibody-like recognition specificities Immunity 2012; 36:79-91.
36. Gao GF, Willcox BE, Wyer JR et al. Classical and nonclassical class I major histocompatibility complex molecules exhibit subtle conformational differences that affect binding to CD8αα. J Biol Chem 2000; 275:15232-8.
37. Wyer JR, Willcox BE, Gao GF, Gerth UC, Davis SJ, Bell JI, van der Merwe PA, Jakobsen BK. T cell receptor and coreceptor CD8αα bind peptide-MHC independently and with distinct kinetics. Immunity 1999; 10:219-25.
38. Hutchinson SL, Wooldridge L, Tafuro S et al. The CD8 T cell coreceptor exhibits disproportionate biological activity at extremely low binding affinities. J Biol Chem 2003; 278:24285-93.
39. Garcia KC, Scott CA, Brunmark A, Carbone FR, Peterson PA, Wilson IA, Teyton L. CD8 enhances formation of stable T-cell receptor/MHC class I molecule complexes. Nature 1996; 384:577-81.
40. Moody AM, Xiong Y, Chang HC, Reinherz EL. The CD8αβ co-receptor on double-positive thymocytes binds with differing affinities to the products of distinct class I MHC loci. Eur J Immunol 2001; 31:2791-9.
41. Yachi PP, Ampudia J, Zal T, Gascoigne NR. Altered peptide ligands induce delayed CD8-T cell receptor interaction-a role for CD8 in distinguishing antigen quality. Immunity 2006; 25:203-11.
42. Hampl J, Chien YH, Davis MM. CD4 augments the response of a T cell to agonist but not to antagonist ligands. Immunity 1997; 7:379-85.
43. Madrenas J, Chau LA, Smith J, Bluestone JA, Germain RN. The efficiency of CD4 recruitment to ligand-engaged TCR controls the agonist/partial agonist properties of peptide-MHC molecule ligands. J Exp Med 1997; 185:219-29.
44. Cole DK, Dunn SM, Sami M, Boulter JM, Jakobsen BK, Sewell AK. T cell receptor engagement of peptide-major histocompatibility complex class I does not modify CD8 binding. Mol Immunol 2008; 45:2700-9.
45. Cole DK, Pumphrey NJ, Boulter JM et al. Human TCR-binding affinity is governed by MHC Class restriction. J Immunol 2007; 178:5727-34.
46. Davis MM, Boniface JJ, Reich Z, Lyons D, Hampl J, Arden B, Chien Y. Ligand recognition by αβ T cell receptors. Annu Rev Immunol 1998; 16:523-44.
47. Stone JD, Chervin AS, Kranz DM. T-cell receptor binding affinities and kinetics: impact on T-cell activity and specificity. Immunology 2009; 126:165-76.
48. Varela-Rohena A, Molloy PE, Dunn SM et al. Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor. Nat Med 2008; 14:1390-5.
49. Wooldridge L, Clement M, Lissina A et al. MHC class I molecules with Superenhanced CD8 binding properties bypass the requirement for cognate TCR recognition and nonspecifically activate CTLs. J Immunol 2010; 184:3357-66.
50. Campanelli R, Palermo B, Garbelli S, Mantovani S, Lucchi P, Necker A, Lantelme E, Giachino C. Human CD8 co-receptor is strictly involved in MHC-peptide tetramer-TCR binding and T cell activation. Int Immunol 2002; 14:39-44.
51. Daniels MA, Devine L, Miller JD et al. CD8 binding to MHC class I molecules is influenced by T cell maturation and glycosylation. Immunity 2001; 15:1051-61.
52. Denkberg G, Cohen CJ, Reiter Y. Critical role for CD8 in binding of MHC tetramers to TCR: CD8 antibodies block specific binding of human tumor-specific MHC-peptide tetramers to TCR. J Immunol 2001; 167:270-6.
53. Wooldridge L, Hutchinson SL, Choi EM et al. Anti-CD8 antibodies can inhibit or enhance peptide-MHC class I (pMHCI) multimer binding: this is paralleled by their effects on CTL activation and occurs in the absence of an interaction between pMHCI and CD8 on the cell surface. J Immunol 2003; 171:6650-60.
54. + T cell effector function in the absence of TCR engagement and improve peptide-MHCI tetramer staining. J Immunol 2011; 187:654-63.
55. Alam SM, Travers PJ, Wung JL, Nasholds W, Redpath S, Jameson SC, Gascoigne NR. T-cell-receptor affinity and thymocyte positive selection. Nature 1996; 381:616-20.
56. Colf LA, Bankovich AJ, Hanick NA, Bowerman NA, Jones LL, Kranz DM, Garcia KC. How a single T cell receptor recognizes both self and foreign MHC. Cell 2007; 129:135-46.
57. Garcia KC, Tallquist MD, Pease LR et al. αβ T cell receptor interactions with syngeneic and allogeneic ligands: affinity measurements and crystallization. Proc Natl Acad Sci U S A 1997; 94:13838-43.
58. Reiser JB, Darnault C, Guimezanes A et al. Crystal structure of a T cell receptor bound to an allogeneic MHC molecule. Nat Immunol 2000; 1:291-7.
59. Willcox BE, Gao GF, Wyer JR, Ladbury JE, Bell JI, Jakobsen BK, van der Merwe PA. TCR binding to peptide-MHC stabilizes a flexible recognition interface. Immunity 1999; 10:357-65.
60. Borbulevych OY, Piepenbrink KH, Gloor BE, Scott DR, Sommese RF, Cole DK, Sewell AK, Baker BM. T cell receptor cross-reactivity directed by antigen-dependent tuning of peptide-MHC molecular flexibility. Immunity 2009; 31:885-96.
61. Borg NA, Ely LK, Beddoe T et al. The CDR3 regions of an immunodominant T cell receptor dictate the 'energetic landscape' of peptide-MHC recognition. Nat Immunol 2005; 6:171-80.
62. Davis-Harrison RL, Armstrong KM, Baker BM. Two different T cell receptors use different thermodynamic strategies to recognize the same peptide/MHC ligand. J Mol Biol 2005; 346:533-50.
63. Ding YH, Baker BM, Garboczi DN, Biddison WE, Wiley DC. Four A6-TCR/peptide/HLA-A2 structures that generate very different T cell signals are nearly identical. Immunity 1999; 11:45-56.
64. Gakamsky DM, Luescher IF, Pecht I. T cell receptor-ligand interactions: a conformational preequilibrium or an induced fit. Proc Natl Acad Sci U S A 2004; 101:9063-6.
65. Laugel B, Boulter JM, Lissin N et al. Design of soluble recombinant T cell receptors for antigen targeting and T cell inhibition. J Biol Chem 2005; 280:1882-92.
66. van der Merwe PA, Davis SJ. Molecular interactions mediating T cell antigen recognition. Annu Rev Immunol 2003; 21:659-84.
67. Naeher D, Daniels MA, Hausmann B, Guillaume P, Luescher I, Palmer E. A constant affinity threshold for T cell tolerance. J Exp Med 2007; 204:2553-9.
68. Wooldridge L, Scriba TJ, Milicic A, Laugel B, Gostick E, Price DA, Phillips RE, Sewell AK. Anti-coreceptor antibodies profoundly affect staining with peptide-MHC class I and class II tetramers. Eur J Immunol 2006; 36:1847-55.
69. Jiang N, Huang J, Edwards LJ, Liu B, Zhang Y, Beal CD, Evavold BD, Zhu C. Two-stage cooperative T cell receptor-peptide major histocompatibility complex-CD8 trimolecular interactions amplify antigen discrimination. Immunity 2011; 34:13-23.
70. Choksi S, Jameson BA, Korngold R. A structure-based approach to designing synthetic CD8α peptides that can inhibit cytotoxic T-lymphocyte responses. Nat Med 1998; 4:309-14.
71. Kern P, Hussey RE, Spoerl R, Reinherz EL, Chang HC. Expression, purification, and functional analysis of murine ectodomain fragments of CD8αα and CD8αβ dimers. J Biol Chem 1999; 274:27237-43.
72. Sewell AK, Gerth UC, Price DA et al. Antagonism of cytotoxic T-lymphocyte activation by soluble CD8. Nat Med 1999; 5:399-404.
73. - T cell transfectants that express a high affinity T cell receptor exhibit enhanced peptide-dependent activation. J Exp Med 2001; 194:1043-52.
74. Wooldridge L, Lissina A, Vernazza J et al. Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant region. Eur J Immunol 2007; 37:1323-33.
75. Wooldridge L, Laugel B, Ekeruche J, Clement M, van den Berg HA, Price DA, Sewell AK. CD8 controls T cell cross-reactivity. J Immunol 2010; 185:4625-32.
76. Isewell AK. Why must T cells be cross-reactive. Nat Rev Immunol 2002; 12, doi: 10.1038/nri327910.1038/nri3279.
77. Laugel B, Cole DK, Clement M, Wooldridge L, Price DA, Sewell AK. The multiple roles of the CD8 coreceptor in T cell biology: opportunities for the selective modulation of self-reactive cytotoxic T cells. J Leukoc Biol 2011; 90:1089-99.
78. Cole DK, Rizkallah PJ, Boulter JM et al. Computational design and crystal structure of an enhanced affinity mutant human CD8αα coreceptor. Proteins 2007; 67:65-74.
79. + T-cell clonotypes by HIV. Blood 2011; 118:2138-49.